PolyNovo Limited
CALZFOTCHealthcare● Active
$0.60
$-0.20(-24.59%)
Market Cap$414505795
P/E Ratio—
52W High$1.02
52W Low$0.55
PolyNovo Limited (CALZF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CALZF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 25, 2025EPS Actual
$0.01
Est. $0.00 · +140.7%
Revenue
$0.04B
Est. $0.05B · -2.9%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 25, 2025
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 2-Quarter EPS Beat Streak
CALZF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 21, 2026 | $0.01 | — | — | — | $0.05B | — |
| ◌ Q1 FY2026 | Feb 20, 2026 | $0.00 | — | — | $0.05B | $0.05B | +9.9% |
| ▲ Q3 FY2025 | Aug 25, 2025 | $0.00 | $0.01 | +140.7% | $0.04B | $0.05B | -2.9% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $0.00 | $0.00 | +6.1% | $0.04B | $0.04B | -0.6% |
| ▼ Q3 FY2024 | Aug 22, 2024 | $0.00 | $0.00 | -26.7% | $0.04B | $0.04B | -0.8% |
| — Q2 FY2024 | May 8, 2024 | — | $0.00 | — | $0.03B | $0.03B | -3.1% |
| ▲ Q2 FY2023 | Jun 30, 2023 | -$0.01 | -$0.00 | +84.1% | $0.02B | $0.02B | +27.8% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $0.00 | -$0.00 | -389.0% | $0.02B | $0.02B | -0.2% |
Q3 FY2026
Aug 21, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 20, 2026
EPS Actual
—
EPS Est.
$0.00
EPS Surpr.
—
Revenue
$0.05B
Q3 FY2025
Aug 25, 2025Beat
EPS Actual
$0.01
EPS Est.
$0.00
EPS Surpr.
+140.7%
Revenue
$0.04B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.00
EPS Est.
$0.00
EPS Surpr.
+6.1%
Revenue
$0.04B
Q3 FY2024
Aug 22, 2024Miss
EPS Actual
$0.00
EPS Est.
$0.00
EPS Surpr.
-26.7%
Revenue
$0.04B
Q2 FY2024
May 8, 2024
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
-$0.00
EPS Est.
-$0.01
EPS Surpr.
+84.1%
Revenue
$0.02B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
-$0.00
EPS Est.
$0.00
EPS Surpr.
-389.0%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.01 | $0.01 | $0.01 | 1 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2023 | $-0.00 | $-0.00 | $-0.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2023 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2025 | Aug 25, 2025 | +140.7% | $0.69 | $0.82 | +18.80% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +6.1% | $1.11 | $0.95 | -14.86% |
| ▼ Q3 FY2024 | Aug 22, 2024 | -26.7% | $1.65 | $1.65 | +0.00% |
| — Q2 FY2024 | May 8, 2024 | — | $1.35 | $1.53 | +13.33% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +84.1% | $1.35 | $1.05 | -22.22% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -389.0% | $1.19 | $1.40 | +17.65% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -323.2% | $1.25 | $1.00 | -20.00% |
| ▲ Q4 FY2021 | Dec 31, 2021 | +161.0% | $1.15 | $1.50 | +30.43% |
Q3 FY2025+18.80%
Report Date
Aug 25, 2025
EPS Beat/Miss
+140.7%
Price Before
$0.69
Price After
$0.82
Q1 FY2025-14.86%
Report Date
Feb 25, 2025
EPS Beat/Miss
+6.1%
Price Before
$1.11
Price After
$0.95
Q3 FY2024+0.00%
Report Date
Aug 22, 2024
EPS Beat/Miss
-26.7%
Price Before
$1.65
Price After
$1.65
Q2 FY2024+13.33%
Report Date
May 8, 2024
EPS Beat/Miss
—
Price Before
$1.35
Price After
$1.53
Q2 FY2023-22.22%
Report Date
Jun 30, 2023
EPS Beat/Miss
+84.1%
Price Before
$1.35
Price After
$1.05
Q4 FY2022+17.65%
Report Date
Dec 31, 2022
EPS Beat/Miss
-389.0%
Price Before
$1.19
Price After
$1.40
Q2 FY2022-20.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-323.2%
Price Before
$1.25
Price After
$1.00
Q4 FY2021+30.43%
Report Date
Dec 31, 2021
EPS Beat/Miss
+161.0%
Price Before
$1.15
Price After
$1.50
Avg Beat Reaction+3.04%
Avg Miss Reaction-0.78%
Beat Rate4 / 8 quarters
Largest Move+30.43% (Q4 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CALZF ends December
PolyNovo Limited (CALZF) most recently reported earnings on August 25, 2025 for Q3 FY2025, posting EPS of $0.01 — beating the analyst consensus of $0.00 by +140.7%. CALZF has beaten EPS estimates for 2 consecutive quarters. The next CALZF earnings date is expected around September 1, 2026.
Each quarter, investors track CALZF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CALZF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CALZF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CALZF earnings · 5 questionsPolyNovo Limited's next earnings report is expected around September 1, 2026. CALZF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CALZF historically reports after market close (AMC).
CALZF earnings datewhen is CALZF earningsCALZF next earnings datewhen does CALZF report earningsCALZF earnings calendar
▸ Source: FMP · PolyNovo Limited SEC filings · US GAAP · PolyNovo Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026